{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:25:08Z","timestamp":1791267908038,"version":"4.1.0"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1093\/carcin\/bgn086","type":"journal-article","created":{"date-parts":[[2008,3,29]],"date-time":"2008-03-29T20:24:13Z","timestamp":1206822253000},"page":"1373-1379","source":"Crossref","is-referenced-by-count":90,"title":["Role of ING4 in human melanoma cell migration, invasion and patient survival"],"prefix":"10.1093","volume":"29","author":[{"given":"Jun","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Martinka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2008,3,28]]},"reference":[{"key":"key\n\t\t\t\t20170520232348_bib1","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3322\/canjclin.57.1.43","article-title":"Cancer statistics, 2007","volume":"57","author":"Jemal","year":"2007","journal-title":"CA Cancer J. Clin."},{"key":"key\n\t\t\t\t20170520232348_bib2","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1038\/sj.onc.1206454","article-title":"Apoptosis and melanoma chemoresistance","volume":"22","author":"Soengas","year":"2003","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t20170520232348_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1023\/A:1013123532723","article-title":"Drug resistance in melanoma: mechanisms, apoptosis, and new potential therapeutic targets","volume":"20","author":"Grossman","year":"2001","journal-title":"Cancer Metastasis Rev."},{"key":"key\n\t\t\t\t20170520232348_bib4","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0039-6109(02)00096-8","article-title":"Radiation therapy for malignant melanoma","volume":"83","author":"Ballo","year":"2003","journal-title":"Surg. Clin. North Am."},{"key":"key\n\t\t\t\t20170520232348_bib5","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.1445-5994.2002.00289.x","article-title":"Adjuvant therapy for high-risk primary and resected metastatic melanoma","volume":"33","author":"Hersey","year":"2003","journal-title":"Intern. Med. J."},{"key":"key\n\t\t\t\t20170520232348_bib6","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1056\/NEJMra052166","article-title":"Melanoma","volume":"355","author":"Miller","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"key\n\t\t\t\t20170520232348_bib7","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1016\/j.ejca.2005.03.034","article-title":"Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors","volume":"41","author":"Gandini","year":"2005","journal-title":"Eur. J. Cancer"},{"key":"key\n\t\t\t\t20170520232348_bib8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejca.2004.10.016","article-title":"Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure","volume":"41","author":"Gandini","year":"2005","journal-title":"Eur. J. Cancer"},{"key":"key\n\t\t\t\t20170520232348_bib9","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ejca.2004.10.015","article-title":"Meta-analysis of risk factors for cutaneous melanoma: I. Common and a typical naevi","volume":"41","author":"Gandini","year":"2005","journal-title":"Eur. J. Cancer"},{"key":"key\n\t\t\t\t20170520232348_bib10","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1158\/0008-5472.CAN-05-3444","article-title":"The novel tumor suppressor p33ING2 enhances nucleotide excision repair via inducement of histone H4 acetylation and chromatin relaxation","volume":"66","author":"Wang","year":"2006","journal-title":"Cancer Res."},{"key":"key\n\t\t\t\t20170520232348_bib11","first-page":"2373","article-title":"p29ING4 and p28ING5 bind to p53 and p300, and enhance p53 activity","volume":"63","author":"Shiseki","year":"2003","journal-title":"Cancer Res."},{"key":"key\n\t\t\t\t20170520232348_bib12","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nature02329","article-title":"The candidate tumour suppressor protein ING4 regulates brain tumour growth and angiogenesis","volume":"428","author":"Garkavtsev","year":"2004","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170520232348_bib13","doi-asserted-by":"crossref","first-page":"7481","DOI":"10.1073\/pnas.0502716102","article-title":"The candidate tumor suppressor ING4 represses activation of the hypoxia inducible factor (HIF)","volume":"102","author":"Ozer","year":"2005","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"key\n\t\t\t\t20170520232348_bib14","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1200\/JCO.2005.07.168","article-title":"Prognostic significance of activated Akt expression in melanoma: a clinicopathologic study of 292 cases","volume":"23","author":"Dai","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"key\n\t\t\t\t20170520232348_bib15","first-page":"138","article-title":"Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue","volume":"8","author":"Remmele","year":"1987","journal-title":"Pathologe"},{"key":"key\n\t\t\t\t20170520232348_bib16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00008390-199802000-00004","article-title":"Chemotherapy-induced apoptosis in melanoma cells is p53 dependent","volume":"8","author":"Li","year":"1998","journal-title":"Melanoma Res."},{"key":"key\n\t\t\t\t20170520232348_bib17","doi-asserted-by":"crossref","first-page":"11887","DOI":"10.1074\/jbc.M511309200","article-title":"ING3 promotes UV-induced apoptosis via Fas\/caspase-8 pathway in melanoma cells","volume":"281","author":"Wang","year":"2006","journal-title":"J. Biol. Chem."},{"key":"key\n\t\t\t\t20170520232348_bib18","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.yexcr.2004.11.023","article-title":"The novel tumor suppressor p33ING2 enhances UVB-induced apoptosis in human melanoma cells","volume":"304","author":"Chin","year":"2005","journal-title":"Exp. Cell Res."},{"key":"key\n\t\t\t\t20170520232348_bib19","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1158\/1535-7163.MCT-07-0134","article-title":"The role of integrin-linked kinase in melanoma cell migration, invasion, and tumor growth","volume":"6","author":"Wong","year":"2007","journal-title":"Mol. Cancer Ther."},{"key":"key\n\t\t\t\t20170520232348_bib20","doi-asserted-by":"crossref","first-page":"34677","DOI":"10.1074\/jbc.M606296200","article-title":"Novel splice variants of ING4 and their possible roles in the regulation of cell growth and motility","volume":"281","author":"Unoki","year":"2006","journal-title":"J. Biol. Chem."},{"key":"key\n\t\t\t\t20170520232348_bib21","first-page":"73","article-title":"Mutations of the ING1 tumor suppressor gene detected in human melanoma abrogate nucleotide excision repair","volume":"25","author":"Campos","year":"2004","journal-title":"Int. J. Oncol."},{"key":"key\n\t\t\t\t20170520232348_bib22","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1046\/j.1365-2559.2002.01369.x","article-title":"Nuclear to cytoplasmic compartment shift of the p33ING1b tumour suppressor protein is associated with malignancy in melanocytic lesions","volume":"40","author":"Nouman","year":"2002","journal-title":"Histopathology"},{"key":"key\n\t\t\t\t20170520232348_bib23","doi-asserted-by":"crossref","first-page":"4111","DOI":"10.1158\/1078-0432.CCR-07-0408","article-title":"Prognostic significance of nuclear ING3 expression in human cutaneous melanoma","volume":"13","author":"Wang","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"key\n\t\t\t\t20170520232348_bib24","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/sj.bjc.6603205","article-title":"Nuclear ING2 expression is reduced in human cutaneous melanomas","volume":"95","author":"Lu","year":"2006","journal-title":"Br. J. Cancer"},{"key":"key\n\t\t\t\t20170520232348_bib25","first-page":"4974","article-title":"The tumor suppressor candidate p33(ING1) mediates repair of UV-damaged DNA","volume":"61","author":"Cheung","year":"2001","journal-title":"Cancer Res."},{"key":"key\n\t\t\t\t20170520232348_bib26","doi-asserted-by":"crossref","first-page":"3787","DOI":"10.1016\/j.febslet.2006.05.065","article-title":"Leucine zipper-like domain is required for tumor suppressor ING2-mediated nucleotide excision repair and apoptosis","volume":"580","author":"Wang","year":"2006","journal-title":"FEBS Lett."},{"key":"key\n\t\t\t\t20170520232348_bib27","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1006\/excr.2002.5610","article-title":"p33(ING1) enhances UVB-induced apoptosis in melanoma cells","volume":"279","author":"Cheung","year":"2002","journal-title":"Exp. Cell Res."},{"key":"key\n\t\t\t\t20170520232348_bib28","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.gene.2005.02.014","article-title":"Frequent deletion and down-regulation of ING4, a candidate tumor suppressor gene at 12p13, in head and neck squamous cell carcinomas","volume":"356","author":"Gunduz","year":"2005","journal-title":"Gene"},{"key":"key\n\t\t\t\t20170520232348_bib29","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.cancergencyto.2005.08.021","article-title":"Diversity of cytogenetic and pathohistologic profiles in glioblastoma","volume":"166","author":"Hassler","year":"2006","journal-title":"Cancer Genet. Cytogenet."},{"key":"key\n\t\t\t\t20170520232348_bib30","doi-asserted-by":"crossref","first-page":"16251","DOI":"10.1073\/pnas.0407158101","article-title":"A screen for genes that suppress loss of contact inhibition: identification of ING4 as a candidate tumor suppressor gene in human cancer","volume":"101","author":"Kim","year":"2004","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"key\n\t\t\t\t20170520232348_bib31","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/nature03890","article-title":"BRAFE600-associated senescence-like cell cycle arrest of human naevi","volume":"436","author":"Michaloglou","year":"2005","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170520232348_bib32","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nature03918","article-title":"Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis","volume":"436","author":"Chen","year":"2005","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170520232348_bib33","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1158\/0008-5472.CAN-05-4006","article-title":"Oncogene-induced senescence: putting the brakes on tumor development","volume":"66","author":"Braig","year":"2006","journal-title":"Cancer Res."},{"key":"key\n\t\t\t\t20170520232348_bib34","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1158\/0008-5472.CAN-03-0005","article-title":"Involvement of Rel\/nuclear factor-kappaB transcription factors in keratinocyte senescence","volume":"64","author":"Bernard","year":"2004","journal-title":"Cancer Res."},{"key":"key\n\t\t\t\t20170520232348_bib35","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1158\/0008-5472.CAN-06-3870","article-title":"Inhibitor of growth 4 suppresses cell spreading and cell migration by interacting with a novel binding partner, liprin alpha1","volume":"67","author":"Shen","year":"2007","journal-title":"Cancer Res."},{"key":"key\n\t\t\t\t20170520232348_bib36","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/(SICI)1096-9896(199611)180:3<283::AID-PATH662>3.0.CO;2-3","article-title":"Matrix metalloproteinase-2 (72 kD type IV collagenase) expression occurs in the early stage of human melanocytic tumour progression and may have prognostic value","volume":"180","author":"Vaisanen","year":"1996","journal-title":"J. Pathol."},{"key":"key\n\t\t\t\t20170520232348_bib37","first-page":"665","article-title":"Expression of gelatinase B and the extracellular matrix metalloproteinase inducer EMMPRIN in benign and malignant pigment cell lesions of the skin","volume":"151","author":"van den Oord","year":"1997","journal-title":"Am. J. Pathol."},{"key":"key\n\t\t\t\t20170520232348_bib38","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1046\/j.1523-1747.2000.00068.x","article-title":"Matrix metalloproteinases in human melanoma","volume":"115","author":"Hofmann","year":"2000","journal-title":"J. Invest. Dermatol."},{"key":"key\n\t\t\t\t20170520232348_bib39","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.febslet.2004.06.010","article-title":"ING4 induces G2\/M cell cycle arrest and enhances the chemosensitivity to DNA-damage agents in HepG2 cells","volume":"570","author":"Zhang","year":"2004","journal-title":"FEBS Lett."},{"key":"key\n\t\t\t\t20170520232348_bib40","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.4161\/cc.4.9.2040","article-title":"Regulation of HIF by prolyl hydroxylases: recruitment of the candidate tumor suppressor protein ING4","volume":"4","author":"Ozer","year":"2005","journal-title":"Cell Cycle"},{"key":"key\n\t\t\t\t20170520232348_bib41","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1002\/1097-0142(19931001)72:7<2219::AID-CNCR2820720725>3.0.CO;2-J","article-title":"Prognosis and treatment of disseminated uveal melanoma","volume":"72","author":"Kath","year":"1993","journal-title":"Cancer"},{"key":"key\n\t\t\t\t20170520232348_bib42","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.1200\/JCO.2001.19.16.3622","article-title":"Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system","volume":"19","author":"Balch","year":"2001","journal-title":"J. Clin. Oncol."}],"container-title":["Carcinogenesis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/carcin\/article-pdf\/29\/7\/1373\/17286083\/bgn086.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T08:36:18Z","timestamp":1503563778000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/carcin\/article-lookup\/doi\/10.1093\/carcin\/bgn086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3,28]]},"references-count":42,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2008,3,28]]},"published-print":{"date-parts":[[2008,7]]}},"URL":"https:\/\/doi.org\/10.1093\/carcin\/bgn086","relation":{},"ISSN":["1460-2180","0143-3334"],"issn-type":[{"value":"1460-2180","type":"electronic"},{"value":"0143-3334","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3,28]]}}}